Clearance Summary
Endobronchial Blocker Tube (EBT0109); Endobronchial Blocker Tube (EBT0107); Endobronchial Blocker Tube (EBT0105); Endobronchial Blocker Tube (EBT0109S); Endobronchial Blocker Tube (EBT0107S); Endobronchial Blocker Tube (EBT0105S); Endobronchial Blocker Tube (EBT0209); Endobronchial Blocker Tube (EBT0207); Endobronchial Blocker Tube (EBT0205); Endobronchial Blocker Tube (EBT0209S); Endobronchial Blocker Tube (EBT0207S); Endobronchial Blocker Tube (EBT0205S) received FDA 510(k) clearance under submission number K251950, sponsored by Hangzhou Tappa Medical Technology Co., Ltd.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Anesthesiology review panel. The statutory decision date of record is 2026-03-20.
- Submission: K251950
- Applicant / Sponsor: Hangzhou Tappa Medical Technology Co., Ltd.
- Clearance pathway: Traditional
- Review panel: Anesthesiology
- Device class: Class II
- Regulation citation: 21 CFR 868.5740
- Decision date: 2026-03-20
Classification & Regulation
This clearance is catalogued under FDA product code CBI and 21 CFR 868.5740, within the Anesthesiology review panel as a Class II device.